Literature DB >> 18548287

Recent advances in pediatric dialysis: a review of selected articles.

John D Mahan1, Hiren P Patel.   

Abstract

Important discoveries and studies that help inform us about the best methods to evaluate and manage children with end-stage renal disease (ESRD) continue to emerge. This review addresses a number of recent publications regarding important clinical issues for children with ESRD. Despite advances made in previous years, many clinical problems remain in the care of the pediatric dialysis patient. This review covers five topics of recent interest: three articles that address important patient outcome measures such as dialysis adequacy and hemoglobin; two articles that address growth failure in a chronic dialysis patients; five articles that address cardiovascular (CV) morbidity, mortality, and interventions to reduce CV risk in children; two articles that address mineral-bone disorder (MBD) and evidence that past strategies for MBD in children may have increased CV disease; and two articles that address nephrogenic systemic fibrosis, a recently described disorder in chronic kidney disease (CKD) patients that occurs in children as well as adults. Using a concise consistent format, each of the 14 key publications is summarized, and the "conclusion" for the practitioner is identified. The goal of this review is to highlight important work done in this area and focus attention on the important issues raised by each article.

Entities:  

Mesh:

Year:  2008        PMID: 18548287     DOI: 10.1007/s00467-008-0825-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

1.  A pediatric case of nephrogenic fibrosing dermopathy: improvement after combination therapy.

Authors:  Joshua B DiCarlo; Erica A Gupta; Alvin R Solomon
Journal:  J Am Acad Dermatol       Date:  2006-05       Impact factor: 11.527

2.  Association of mortality and hospitalization with achievement of adult hemoglobin targets in adolescents maintained on hemodialysis.

Authors:  Sandra Amaral; Wenke Hwang; Barbara Fivush; Alicia Neu; Diane Frankenfield; Susan Furth
Journal:  J Am Soc Nephrol       Date:  2006-08-30       Impact factor: 10.121

3.  How to read the new recommendation statement: methods update from the U.S. Preventive Services Task Force.

Authors:  Mary B Barton; Therese Miller; Tracy Wolff; Diana Petitti; Michael LeFevre; George Sawaya; Barbara Yawn; Janelle Guirguis-Blake; Ned Calonge; Russell Harris
Journal:  Ann Intern Med       Date:  2007-06-18       Impact factor: 25.391

4.  Severe cardiac hypertrophy and long-term dialysis: the Midwest Pediatric Nephrology Consortium study.

Authors:  Mark M Mitsnefes; Gina M Barletta; Ian G Dresner; Deepa H Chand; Denis Geary; Jen-Jar Lin; Hiren Patel
Journal:  Pediatr Nephrol       Date:  2006-06-29       Impact factor: 3.714

5.  Coronary artery calcifications in children with end-stage renal disease.

Authors:  Mahmut Civilibal; Salim Caliskan; Ibrahim Adaletli; Huseyin Oflaz; Lale Sever; Cengiz Candan; Nur Canpolat; Ozgur Kasapcopur; Sebuh Kuruoglu; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2006-07-04       Impact factor: 3.714

6.  Reduction of left ventricular hypertrophy in children undergoing hemodialysis.

Authors:  Tim Ulinski; Julie Genty; Christine Viau; Isabelle Tillous-Borde; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2006-06-01       Impact factor: 3.714

7.  Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients.

Authors:  Wacharee Seeherunvong; Obioma Nwobi; Carolyn L Abitbol; Jayanthi Chandar; José Strauss; Gastón Zilleruelo
Journal:  Pediatr Nephrol       Date:  2006-08-10       Impact factor: 3.714

8.  Comparison of single-pool and equilibrated Kt/V values for pediatric hemodialysis prescription management: analysis from the Centers for Medicare & Medicaid Services Clinical Performance Measures Project.

Authors:  Stuart L Goldstein; Andrew Brem; Bradley A Warady; Barbara Fivush; Diane Frankenfield
Journal:  Pediatr Nephrol       Date:  2006-05-17       Impact factor: 3.714

9.  Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis.

Authors:  Danuta Zwołińska; Władysław Grzeszczak; Maria Szczepańska; Katarzyna Kiliś-Pstrusińska; Krystyna Szprynger
Journal:  Pediatr Nephrol       Date:  2006-03-04       Impact factor: 3.714

10.  Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy.

Authors:  Sonia Briese; Sandra Wiesner; Joachim C Will; Alexander Lembcke; Bernd Opgen-Rhein; Richard Nissel; Klaus-Dieter Wernecke; Judit Andreae; Dieter Haffner; Uwe Querfeld
Journal:  Nephrol Dial Transplant       Date:  2006-03-22       Impact factor: 5.992

View more
  2 in total

1.  Optimal hemodialysis prescription: do children need more than a urea dialysis dose?

Authors:  Fischbach Michel; Zaloszyc Ariane; Schaefer Betti; Schmitt Claus Peter
Journal:  Int J Nephrol       Date:  2011-05-16

2.  Attention-deficit/hyperactivity disorder in children undergoing peritoneal dialysis.

Authors:  Parsa Yousefichaijan; Mojtaba Sharafkhah; Shams Vazirian; Abolhasan Seyedzadeh; Mohammad Rafeie; Bahman Salehi; Mohammad Amiri; Mohsen Ebrahimimonfared
Journal:  Nephrourol Mon       Date:  2015-03-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.